Published in Pharmacogenetics on October 01, 1993
Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol (2011) 1.38
Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc Natl Acad Sci U S A (1996) 1.35
Cancer treatment and pharmacogenetics of cytochrome P450 enzymes. Invest New Drugs (2005) 1.09
Animal models of human response to dioxins. Environ Health Perspect (1998) 1.05
DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet (2002) 1.03
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver. Front Pharmacol (2010) 0.93
Mitochondrial targeting of cytochrome P450 (CYP) 1B1 and its role in polycyclic aromatic hydrocarbon-induced mitochondrial dysfunction. J Biol Chem (2014) 0.89
Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer (1999) 0.89
Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2. Eur J Clin Pharmacol (2012) 0.87
Enhanced expression of cytochrome P450 in stomach cancer. Br J Cancer (1998) 0.85
Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study. Int J Cancer (2011) 0.83
Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats. PLoS One (2014) 0.80
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. Br J Clin Pharmacol (1999) 0.79
Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma. World J Hepatol (2010) 0.78
Transient gene delivery for functional enrichment of differentiating embryonic stem cells. Biotechnol Bioeng (2008) 0.76
Gene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa. Inhal Toxicol (2015) 0.75
In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation. Pharmacol Res Perspect (2017) 0.75
A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study. Chem Sci (2016) 0.75
CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol Rep (2017) 0.75
Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A (1999) 39.79
Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med (1994) 6.50
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A (2000) 5.47
A randomized trial of a consultation service to reduce falls in nursing homes. JAMA (1997) 4.55
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem (1994) 3.75
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol (1994) 3.05
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
A role for oestrogens in the male reproductive system. Nature (1997) 2.99
Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst (1993) 2.76
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther (2007) 2.54
Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains. Mol Cell Biol (1994) 2.37
The routine use of radiographic spinal displacement analysis: a dissent. J Manipulative Physiol Ther (1999) 2.31
Legionella pneumophila in water plumbing systems. Lancet (1982) 2.25
Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children? J Pediatr (1997) 2.18
Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J (1994) 2.14
A radiographic assessment of the prevalence of pulp stones in Australians. Aust Dent J (2002) 2.13
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells. J Biol Chem (1993) 2.11
Biopsy-induced tricuspid regurgitation after cardiac transplantation. Ann Thorac Surg (1994) 2.07
Bruises in infants and toddlers: those who don't cruise rarely bruise. Puget Sound Pediatric Research Network. Arch Pediatr Adolesc Med (1999) 2.01
Impaired sympathetic vascular regulation in humans after acute dynamic exercise. J Physiol (1996) 1.87
Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem (1993) 1.86
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics (2001) 1.83
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81
Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc (2001) 1.81
Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest (1993) 1.79
Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia (1997) 1.73
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet (2000) 1.68
Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis (1993) 1.62
Surgical management of temporomandibular joint ankylosis in the pediatric population. Plast Reconstr Surg (1993) 1.60
Cranial computed tomography scans in children after minimal head injury with loss of consciousness. Ann Emerg Med (1994) 1.58
Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics (1975) 1.55
Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proc Natl Acad Sci U S A (1997) 1.53
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics (2001) 1.53
An assessment of attitudes to, and extent of, the practice of denture marking in South Australia. Aust Dent J (1998) 1.52
Relationship between epidemiologic risk factors and clinicopathologic findings in the sudden infant death syndrome. Pediatrics (1993) 1.52
Calcium pyrophosphate dihydrate crystal deposition disease and pseudogout of the acromioclavicular joint: radiographic and pathologic features. J Rheumatol (1993) 1.48
Early newborn hospital discharge and readmission for mild and severe jaundice. Arch Pediatr Adolesc Med (1999) 1.46
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother (1988) 1.46
Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. Chest (1992) 1.44
Extrahepatic biliary cystadenomas and cystadenocarcinoma. Report of seven cases and review of the literature. Ann Surg (1995) 1.43
Reversal of sex roles in genetic female mice by disruption of estrogen receptor gene. Neuroendocrinology (1996) 1.42
Tinidazole and metronidazole pharmocokinetics in man and mouse. Antimicrob Agents Chemother (Bethesda) (1969) 1.41
Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J Infect Dis (1979) 1.39
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn (1995) 1.39
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther (2007) 1.39
Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Clin Cancer Res (1995) 1.37
Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med (1993) 1.37
BiP (GRP78) and endoplasmin (GRP94) are induced following rotavirus infection and bind transiently to an endoplasmic reticulum-localized virion component. J Virol (1998) 1.36
Phosphate buffered, low sodium chloride blood agar medium for Legionella pneumophila. Lancet (1981) 1.35
Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J (1992) 1.32
Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice. Infect Immun (1980) 1.32
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther (1995) 1.31
Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial. Med Care (2001) 1.31
Reactions of pediatricians to the recommendation for universal varicella vaccination. Arch Pediatr Adolesc Med (1998) 1.30
Nanonails: a simple geometrical approach to electrically tunable superlyophobic surfaces. Langmuir (2007) 1.28
DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.28
Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys (1998) 1.28
Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab Dispos (2001) 1.27
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog (1996) 1.27
Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract. Biol Reprod (2000) 1.27
Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects. Horm Behav (1997) 1.26
Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther (2001) 1.26
Insulin-like growth factor-I: a key regulator of human cancer risk? J Natl Cancer Inst (1999) 1.24
14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J (2010) 1.23
Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol (1999) 1.23
Development and population study of an eight-locus short tandem repeat (STR) multiplex system. J Forensic Sci (1998) 1.22
Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. Biochemistry (1994) 1.22
Structural and enzymatic aspects of rhodopsin phosphorylation. J Biol Chem (1996) 1.22
Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. J Pharmacol Exp Ther (1997) 1.22
Estrogen receptors are essential for female sexual receptivity. Endocrinology (1997) 1.22
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J Pharmacol Exp Ther (1998) 1.21
Imaging findings in a patient with fibrolipomatous hamartoma of the median nerve. AJR Am J Roentgenol (1993) 1.21
Quantification of mechanical and neural components of vagal baroreflex in humans. Hypertension (2001) 1.21
Automated quantification of sympathetic beat-by-beat activity, independent of signal quality. J Appl Physiol (1985) (2001) 1.20
Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics (1994) 1.19
Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation. Pharmacogenetics (1997) 1.18
In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone. Endocrinology (1999) 1.18
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry (1991) 1.18
Separation of pure polychlorinated biphenyl isomers into two types of inducers on the basis of induction of cytochrome P-450 or P-448. Chem Biol Interact (1977) 1.16
Autonomic mediation of the pressor responses to isometric exercise in humans. J Appl Physiol (1985) (1988) 1.15
Immobilization of the early secretory pathway by a virus glycoprotein that binds to microtubules. EMBO J (2000) 1.15
One-stage anterior cervical decompression and posterior stabilization. A study of one hundred patients with a minimum of two years of follow-up. J Bone Joint Surg Am (1995) 1.14
Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification. Endocrinology (1998) 1.14
Rotavirus nonstructural glycoprotein NSP4 alters plasma membrane permeability in mammalian cells. J Virol (1997) 1.14
Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes. Biochem Pharmacol (1998) 1.13
Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther (1995) 1.13
Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis (2005) 1.13
Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol (2011) 1.12
Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther (2001) 1.12
Controlled breathing protocols probe human autonomic cardiovascular rhythms. Am J Physiol (1998) 1.12
Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res (1997) 1.12
Retinoid target genes in acute promyelocytic leukemia. Leukemia (2003) 1.11
Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab (2001) 1.11
K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev (2000) 1.11
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry (2001) 1.11
Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet (1997) 1.10
Tissue compartment-specific estrogen receptor-alpha participation in the mouse uterine epithelial secretory response. Endocrinology (1999) 1.10
Does reduced vascular stiffening fully explain preserved cardiovagal baroreflex function in older, physically active men? Circulation (2001) 1.09